sales@fnfresearch.comTel: +91 96043 17127 | USA: 1 (347) 690-0211

Search Market Research Report

Home / Category / Biotechnology / Next Generation Sequencing

Next Generation Sequencing Market By Application (Oncology, Clinical Investigation, Reproductive Health, Metagenomics, Epidemiology & Drug Development, Consumer Genomics, Agrigenomics & Forensics and HLA Typing/Immune System Monitoring) By Technology(Whole Genome Sequencing, Whole Exome Sequencing and Targeted Sequencing & Resequencing)By End Use(Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech Entities and Other users): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2020 – 2026

  • Publish On: Apr-2021
  • Total Pages: 195
  • Report Code: FAF-148
  • Base Year: 2020
  • Format:

Industry Insights

[195+ Pages Report] According to the report published by Facts and Factors, the global Next Generation Sequencing market was valued at approximately USD 4,349.2 Million in 2019, and is expected to generate revenue of around USD 12,624.3 Million by end of 2026, growing at a CAGR of around 16.4% between 2020 and 2026.

Global Next Generation Sequencing Market: Overview              

Next-generation sequencing technologies make it possible to sequence RNA and DNA in a reliable and cost-effective manner. These technologies are widely used in functional genomics to test DNA and RNA samples. The demand for next-generation sequencing will grow across all clinical applications. Next-generation sequencing (NGS) refers to large-scale DNA sequencing methods that assist in genome exploration. The term "next-generation sequencing," also known as "high-throughput sequencing," refers to a variety of modern sequencing technologies.

Global Next Generation Sequencing Market: Growth Factors

Because of technical advances in NGS, an increase in NGS applications, and an increase in alliances and collaborations, the global next generation sequencing market is growing. Furthermore, the increase in genome mapping programs propels the global next generation sequencing market forward. However, concerns about standardization in NGS-based diagnostics, a shortage of qualified clinicians, and ethical and legal constraints are expected to stymie the market's growth. On the other hand, lucrative prospects in developing markets, as well as cloud computing as a future data management service, are expected to pay off handsomely for market participants.

Global Next Generation Sequencing Market: Segmentation

The global next generation sequencing market is segregated based application, technology and end-use and regions. 

Oncology, clinical investigation, reproductive health, metagenomics, epidemiology & drug development, consumer genomics, agrigenomics & forensics and HLA typing/immune system monitoring are the application segment of global next generation sequencing market. In 2019, oncology brought in the most revenue, accounting for over 31.3% of total sales. The combination of next-generation sequencing (NGS) and bioinformatics tools has the ability to transform oncology discovery, diagnosis, and treatment. Advances in NGS technology have resulted in advancements in cancer science, signaling the start of cancer's "molecular era." The technology segment is categorized into whole genome sequencing, whole exome sequencing and targeted sequencing & resequencing. Moreover, the report is also categorized end use segment into academic research, clinical research, hospitals & clinics, pharma & biotech entities and other users

Global Next Generation Sequencing Market: Regional Analysis

With a sales share of 47.85% in 2019, North America dominated the global market. The regional market is driven by the involvement of many clinical laboratories that use NGS to provide genetic testing services. In addition, main companies in North America are developing and launching new products, which is boosting business growth. For example, Quest Diagnostics launched the Automated NGS Engine in August 2020 to power AncestryHealth, Ancestry's consumer genetics offering. Genetic screening for blood disorders, bowel cancer, breast cancer, and heart disease is available via the platform.

Due to increased technological advances and funding provided by the government and private organizations, Asia-Pacific is expected to have the highest CAGR during the forecast era. Furthermore, increased investment by biotechnology and pharmaceutical companies is expected to boost consumer demand.

Global Next Generation Sequencing Market: Competitive Players

Some main participants of the Next Generation Sequencing market are Genomatix GmbH, PierianDx; DNASTAR, Inc., Eurofins GATC Biotech GmbH, Illumina, QIAGEN, Thermo Fisher Scientific, Inc., F. Hoffman-La Roche Ltd., Oxford Nanopore Technologies, Perkin Elmer, Inc., Bio-Rad Laboratories, Inc. and BGI amongst others.

Global Next Generation Sequencing : Regional Segment Analysis

  • North America
    • U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

Key Features of Next Generation Sequencing Report:

  • Next Generation Sequencing structure: Overview, industry life cycle analysis, supply chain analysis
  • Next Generation Sequencing : Growth drivers and constraints, Porter’s five forces analysis, SWOT analysis
  • Next Generation Sequencing size, trend, and forecast analysis
  • Next Generation Sequencing segments’ trend and forecast
  • Next Generation Sequencing ’s competitive landscapes: Market share, Product portfolio, New product launches, etc.
  • Next Generation Sequencing attractiveness and associated growth opportunities
  • Emerging trends in the Next Generation Sequencing .
  • Strategic growth opportunities for the existing and new players
  • Key success factors

Benefits of Buying from Facts & Factors:

  • Our proven methodologies and systematic analysis help in making confident business and strategic decisions.
  • A market study that conducts at Facts & Factors Market Research can save significant cost and time, and can help prevent making costly mistakes.

Table of Content

  1. Chapter 1 Executive Summary
    1. 1.1. Introduction of Next Generation Sequencing (NGS)
    2. 1.2. Global Next Generation Sequencing (NGS) Market, 2019 & 2026 (USD Million)
    3. 1.3. Global Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
    4. 1.4. Global Next Generation Sequencing (NGS) Market Absolute Revenue Opportunity, 2016 – 2026 (USD Million)
    5. 1.5. Global Next Generation Sequencing (NGS) Market Incremental Revenue Opportunity, 2020 – 2026 (USD Million)
    6. 1.6. COVID-19 Impacts on Next Generation Sequencing Market
      1. 1.6.1. COVID-19 Impact on the Players
      2. 1.6.2. Business Strategies and Recommendations
  2. Chapter 2 Next Generation Sequencing (NGS) Market – Application Analysis
    1. 2.1. Global Next Generation Sequencing (NGS) Market – Application Overview
    2. 2.2. Global Next Generation Sequencing (NGS) Market Share, by Application, 2019 & 2026 (USD Million)
    3. 2.3. Oncology
      1. 2.3.1. Global Oncology Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
    4. 2.4. Clinical Investigation
      1. 2.4.1. Global Clinical Investigation Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
    5. 2.5. Reproductive Health
      1. 2.5.1. Global Reproductive Health Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
    6. 2.6. Metagenomics, Epidemiology & Drug Development
      1. 2.6.1. Global Metagenomics, Epidemiology & Drug Development Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
    7. 2.7. HLA Typing/Immune System Monitoring
      1. 2.7.1. Global HLA Typing/Immune System Monitoring Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
    8. 2.8. Consumer Genomics
      1. 2.8.1. Global Consumer Genomics Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
    9. 2.9. Agrigenomics & Forensics
      1. 2.9.1. Global Agrigenomics & Forensics Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
  3. Chapter 3 Next Generation Sequencing (NGS) Market – Technology Analysis
    1. 3.1. Global Next Generation Sequencing (NGS) Market – Technology Overview
    2. 3.2. Global Next Generation Sequencing (NGS) Market Share, by Technology, 2019 & 2026 (USD Million)
    3. 3.3. Whole Genome Sequencing
      1. 3.3.1. Global Whole Genome Sequencing Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
    4. 3.4. Whole Exome Sequencing
      1. 3.4.1. Global Whole Exome Sequencing Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
    5. 3.5. Targeted Sequencing & Resequencing
      1. 3.5.1. Global Targeted Sequencing & Resequencing Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
  4. Chapter 4 Next Generation Sequencing (NGS) Market – End-Use Analysis
    1. 4.1. Global Next Generation Sequencing (NGS) Market – End-Use Overview
    2. 4.2. Global Next Generation Sequencing (NGS) Market Share, by End-Use, 2019 & 2026 (USD Million)
    3. 4.3. Academic Research
      1. 4.3.1. Global Academic Research Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
    4. 4.4. Clinical Research
      1. 4.4.1. Global Clinical Research Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
    5. 4.5. Hospitals & Clinics
      1. 4.5.1. Global Hospitals & Clinics Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
    6. 4.6. Pharma & Biotech Entities
      1. 4.6.1. Global Pharma & Biotech Entities Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
    7. 4.7. Other users
      1. 4.7.1. Global Other users Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
  5. Chapter 5 Next Generation Sequencing (NGS) Market – Regional Analysis
    1. 5.1. Global Next Generation Sequencing (NGS) Market Regional Overview
    2. 5.2. Global Next Generation Sequencing (NGS) Market Share, by Region, 2019 & 2026 (USD Million)
    3. 5.3. North America
      1. 5.3.1. North America Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
        1. 5.3.1.1. North America Next Generation Sequencing (NGS) Market, by Country, 2016 - 2026 (USD Million)
      2. 5.3.2. North America Next Generation Sequencing (NGS) Market, by Application, 2016 – 2026
        1. 5.3.2.1. North America Next Generation Sequencing (NGS) Market, by Application, 2016 – 2026 (USD Million)
      3. 5.3.3. North America Next Generation Sequencing (NGS) Market, by Technology, 2016 – 2026
        1. 5.3.3.1. North America Next Generation Sequencing (NGS) Market, by Technology, 2016 – 2026 (USD Million)
      4. 5.3.4. North America Next Generation Sequencing (NGS) Market, by End-Use, 2016 – 2026
        1. 5.3.4.1. North America Next Generation Sequencing (NGS) Market, by End-Use, 2016 – 2026 (USD Million)
      5. 5.3.5. U.S.
        1. 5.3.5.1. U.S. Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
      6. 5.3.6. Canada
        1. 5.3.6.1. Canada Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
    4. 5.4. Europe
      1. 5.4.1. Europe Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
        1. 5.4.1.1. Europe Next Generation Sequencing (NGS) Market, by Country, 2016 - 2026 (USD Million)
      2. 5.4.2. Europe Next Generation Sequencing (NGS) Market, by Application, 2016 – 2026
        1. 5.4.2.1. Europe Next Generation Sequencing (NGS) Market, by Application, 2016 – 2026 (USD Million)
      3. 5.4.3. Europe Next Generation Sequencing (NGS) Market, by Technology, 2016 – 2026
        1. 5.4.3.1. Europe Next Generation Sequencing (NGS) Market, by Technology, 2016 – 2026 (USD Million)
      4. 5.4.4. Europe Next Generation Sequencing (NGS) Market, by End-Use, 2016 – 2026
        1. 5.4.4.1. Europe Next Generation Sequencing (NGS) Market, by End-Use, 2016 – 2026 (USD Million)
      5. 5.4.5. Germany
        1. 5.4.5.1. Germany Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
      6. 5.4.6. France
        1. 5.4.6.1. France Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
      7. 5.4.7. U.K.
        1. 5.4.7.1. U.K. Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
      8. 5.4.8. Italy
        1. 5.4.8.1. Italy Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
      9. 5.4.9. Spain
        1. 5.4.9.1. Spain Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
      10. 5.4.10. Rest of Europe
        1. 5.4.10.1. Rest of Europe Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
    5. 5.5. Asia Pacific
      1. 5.5.1. Asia Pacific Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
        1. 5.5.1.1. Asia Pacific Next Generation Sequencing (NGS) Market, by Country, 2016 - 2026 (USD Million)
      2. 5.5.2. Asia Pacific Next Generation Sequencing (NGS) Market, by Application, 2016 – 2026
        1. 5.5.2.1. Asia Pacific Next Generation Sequencing (NGS) Market, by Application, 2016 – 2026 (USD Million)
      3. 5.5.3. Asia Pacific Next Generation Sequencing (NGS) Market, by Technology, 2016 – 2026
        1. 5.5.3.1. Asia Pacific Next Generation Sequencing (NGS) Market, by Technology, 2016 – 2026 (USD Million)
      4. 5.5.4. Asia Pacific Next Generation Sequencing (NGS) Market, by End-Use, 2016 – 2026
        1. 5.5.4.1. Asia Pacific Next Generation Sequencing (NGS) Market, by End-Use, 2016 – 2026 (USD Million)
      5. 5.5.5. China
        1. 5.5.5.1. China Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
      6. 5.5.6. Japan
        1. 5.5.6.1. Japan Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
      7. 5.5.7. India
        1. 5.5.7.1. India Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
      8. 5.5.8. South Korea
        1. 5.5.8.1. South Korea Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
      9. 5.5.9. South-East Asia
        1. 5.5.9.1. South-East Asia Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
      10. 5.5.10. Rest of Asia Pacific
        1. 5.5.10.1. Rest of Asia Pacific Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
    6. 5.6. Latin America
      1. 5.6.1. Latin America Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
        1. 5.6.1.1. Latin America Next Generation Sequencing (NGS) Market, by Country, 2016 - 2026 (USD Million)
      2. 5.6.2. Latin America Next Generation Sequencing (NGS) Market, by Application, 2016 – 2026
        1. 5.6.2.1. Latin America Next Generation Sequencing (NGS) Market, by Application, 2016 – 2026 (USD Million)
      3. 5.6.3. Latin America Next Generation Sequencing (NGS) Market, by Technology, 2016 – 2026
        1. 5.6.3.1. Latin America Next Generation Sequencing (NGS) Market, by Technology, 2016 – 2026 (USD Million)
      4. 5.6.4. Latin America Next Generation Sequencing (NGS) Market, by End-Use, 2016 – 2026
        1. 5.6.4.1. Latin America Next Generation Sequencing (NGS) Market, by End-Use, 2016 – 2026 (USD Million)
      5. 5.6.5. Brazil
        1. 5.6.5.1. Brazil Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
      6. 5.6.6. Mexico
        1. 5.6.6.1. Mexico Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
      7. 5.6.7. Rest of Latin America
        1. 5.6.7.1. Rest of Latin America Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
    7. 5.7. The Middle-East and Africa
      1. 5.7.1. The Middle-East and Africa Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
        1. 5.7.1.1. The Middle-East and Africa Next Generation Sequencing (NGS) Market, by Country, 2016 - 2026 (USD Million)
      2. 5.7.2. The Middle-East and Africa Next Generation Sequencing (NGS) Market, by Application, 2016 – 2026
        1. 5.7.2.1. The Middle-East and Africa Next Generation Sequencing (NGS) Market, by Application, 2016 – 2026 (USD Million)
      3. 5.7.3. The Middle-East and Africa Next Generation Sequencing (NGS) Market, by Technology, 2016 – 2026
        1. 5.7.3.1. The Middle-East and Africa Next Generation Sequencing (NGS) Market, by Technology, 2016 – 2026 (USD Million)
      4. 5.7.4. The Middle-East and Africa Next Generation Sequencing (NGS) Market, by End-Use, 2016 – 2026
        1. 5.7.4.1. The Middle-East and Africa Next Generation Sequencing (NGS) Market, by End-Use, 2016 – 2026 (USD Million)
      5. 5.7.5. GCC Countries
        1. 5.7.5.1. GCC Countries Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
      6. 5.7.6. South Africa
        1. 5.7.6.1. South Africa Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
      7. 5.7.7. Rest of Middle-East Africa
        1. 5.7.7.1. Rest of Middle-East Africa Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
  6. Chapter 6 Next Generation Sequencing (NGS) Market – Competitive Landscape
    1. 6.1. Competitor Market Share – Revenue
    2. 6.2. Market Concentration Rate Analysis, Top 3 and Top 5 Players
    3. 6.3. Strategic Developments
      1. 6.3.1. Acquisitions and Mergers
      2. 6.3.2. New Products
      3. 6.3.3. Research & Development Activities
  7. Chapter 7 Company Profiles
    1. 7.1. Genomatix GmbH
      1. 7.1.1. Company Overview
      2. 7.1.2. Product/Service Portfolio
      3. 7.1.3. Genomatix GmbH Sales, Revenue, and Gross Margin
      4. 7.1.4. Genomatix GmbH Revenue and Growth Rate
      5. 7.1.5. Genomatix GmbH Market Share
      6. 7.1.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    2. 7.2. PierianDx
      1. 7.2.1. Company Overview
      2. 7.2.2. Product/Service Portfolio
      3. 7.2.3. PierianDx Sales, Revenue, and Gross Margin
      4. 7.2.4. PierianDx Revenue and Growth Rate
      5. 7.2.5. PierianDx Market Share
      6. 7.2.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    3. 7.3. DNASTAR, Inc.
      1. 7.3.1. Company Overview
      2. 7.3.2. Product/Service Portfolio
      3. 7.3.3. DNASTAR, Inc. Sales, Revenue, and Gross Margin
      4. 7.3.4. DNASTAR, Inc. Revenue and Growth Rate
      5. 7.3.5. DNASTAR, Inc. Market Share
      6. 7.3.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    4. 7.4. Illumina
      1. 7.4.1. Company Overview
      2. 7.4.2. Product/Service Portfolio
      3. 7.4.3. Illumina Sales, Revenue, and Gross Margin
      4. 7.4.4. Illumina Revenue and Growth Rate
      5. 7.4.5. Illumina Market Share
      6. 7.4.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    5. 7.5. QIAGEN
      1. 7.5.1. Company Overview
      2. 7.5.2. Product/Service Portfolio
      3. 7.5.3. QIAGEN Sales, Revenue, and Gross Margin
      4. 7.5.4. QIAGEN Revenue and Growth Rate
      5. 7.5.5. QIAGEN Market Share
      6. 7.5.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    6. 7.6. Thermo Fisher Scientific, Inc.
      1. 7.6.1. Company Overview
      2. 7.6.2. Product/Service Portfolio
      3. 7.6.3. Thermo Fisher Scientific, Inc. Sales, Revenue, and Gross Margin
      4. 7.6.4. Thermo Fisher Scientific, Inc. Revenue and Growth Rate
      5. 7.6.5. Thermo Fisher Scientific, Inc. Market Share
      6. 7.6.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
      7. 7.7. F. Hoffman-La Roche Ltd.
      8. 7.7.1. Company Overview
      9. 7.7.2. Product/Service Portfolio
        1. 7.7.3. F. Hoffman-La Roche Ltd. Sales, Revenue, and Gross Margin
        2. 7.7.4. F. Hoffman-La Roche Ltd. Revenue and Growth Rate
        3. 7.7.5. F. Hoffman-La Roche Ltd. Market Share
      10. 7.7.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    7. 7.8. Oxford Nanopore Technologies
      1. 7.8.1. Company Overview
      2. 7.8.2. Product/Service Portfolio
      3. 7.8.3. Oxford Nanopore Technologies Sales, Revenue, and Gross Margin
      4. 7.8.4. Oxford Nanopore Technologies Revenue and Growth Rate
      5. 7.8.5. Oxford Nanopore Technologies Market Share
      6. 7.8.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    8. 7.9. Eurofins GATC Biotech GmbH
      1. 7.9.1. Company Overview
      2. 7.9.2. Product/Service Portfolio
      3. 7.9.3. Eurofins GATC Biotech GmbH Sales, Revenue, and Gross Margin
      4. 7.9.4. Eurofins GATC Biotech GmbH Revenue and Growth Rate
      5. 7.9.5. Eurofins GATC Biotech GmbH Market Share
      6. 7.9.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    9. 7.10. Perkin Elmer, Inc.
      1. 7.10.1. Company Overview
      2. 7.10.2. Product/Service Portfolio
      3. 7.10.3. Perkin Elmer, Inc. Sales, Revenue, and Gross Margin
      4. 7.10.4. Perkin Elmer, Inc. Revenue and Growth Rate
      5. 7.10.5. Perkin Elmer, Inc. Market Share
      6. 7.10.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    10. 7.11. BGI
      1. 7.11.1. Company Overview
      2. 7.11.2. Product/Service Portfolio
      3. 7.11.3. BGI Sales, Revenue, and Gross Margin
      4. 7.11.4. BGI Revenue and Growth Rate
      5. 7.11.5. BGI Market Share
      6. 7.11.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    11. 7.12. Bio-Rad Laboratories, Inc.
      1. 7.12.1. Company Overview
      2. 7.12.2. Product/Service Portfolio
      3. 7.12.3. Bio-Rad Laboratories, Inc. Sales, Revenue, and Gross Margin
      4. 7.12.4. Bio-Rad Laboratories, Inc. Revenue and Growth Rate
      5. 7.12.5. Bio-Rad Laboratories, Inc. Market Share
      6. 7.12.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
  8. Chapter 8 Next Generation Sequencing (NGS) — Industry Analysis
    1. 8.1. Introduction and Taxonomy
    2. 8.2. Next Generation Sequencing (NGS) Market – Key Trends
      1. 8.2.1. Market Drivers
      2. 8.2.2. Market Restraints
      3. 8.2.3. Market Opportunities
    3. 8.3. Value Chain Analysis
    4. 8.4. Key Mandates and Regulations
    5. 8.5. Porter’s Five Forces Model
      1. 8.5.1. Bargaining Power of Buyers
      2. 8.5.2. Bargaining Power of Suppliers
      3. 8.5.3. Threat of Substitute
      4. 8.5.4. Threat of New Entrants
      5. 8.5.5. Rivalry among Existing Competitors
    6. 8.6. PESTEL Analysis
    7. 8.7. SWOT Analysis
    8. 8.8. Technology Roadmap and Timeline
    9. 8.9. Next Generation Sequencing (NGS) Market – Attractiveness Analysis
      1. 8.9.1. By Application
      2. 8.9.2. By Technology
      3. 8.9.3. By End-Use
      4. 8.9.4. By Region
  9. Chapter 9 Report Conclusion & Key Insights
    1. 9.1. Key Insights from Primary Interviews & Surveys Respondents
    2. 9.2. Key Takeaways from Analysts, Consultants, and Industry Leaders
  10. Chapter 10 Research Approach & Methodology
    1. 10.1. Report Description
    2. 10.2. Research Scope
    3. 10.3. Research Methodology
      1. 10.3.1. Secondary Research
      2. 10.3.2. Primary Research
      3. 10.3.3. Statistical Models
        1. 10.3.3.1. Company Share Analysis Model
        2. 10.3.3.2. Revenue Based Modeling
      4. 10.3.4. Research Limitations

      List of Figures

      Fig.1	Product Picture of Next Generation Sequencing (NGS)
      Fig.2	Global Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
      Fig.3	Global Next Generation Sequencing (NGS) Market Absolute Revenue Opportunity, 2016 – 2026 (USD Million)
      Fig.4	Global Next Generation Sequencing (NGS) Market Incremental Revenue Opportunity, 2020 – 2026 (USD Million)
      Fig.5	COVID-19 Impacts on Next Generation Sequencing Market
      Fig.6	COVID-19 Impact on the Players
      Fig.7	Business Strategies and Recommendations
      Fig.8	Global Next Generation Sequencing (NGS) Market Share, by Application, 2019 & 2026 (USD Million)
      Fig.9	Global Oncology Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
      Fig.10	Global Clinical Investigation Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
      Fig.11	Global Reproductive Health Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
      Fig.12	Global Metagenomics, Epidemiology & Drug Development Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
      Fig.13	Global HLA Typing/Immune System Monitoring Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
      Fig.14	Global Consumer Genomics Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
      Fig.15	Global Agrigenomics & Forensics Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
      Fig.16	Global Next Generation Sequencing (NGS) Market Share, by Technology, 2019 & 2026 (USD Million)
      Fig.17	Global Whole Genome Sequencing Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
      Fig.18	Global Whole Exome Sequencing Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
      Fig.19	Global Targeted Sequencing & Resequencing Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
      Fig.20	Global Next Generation Sequencing (NGS) Market Share, by End-Use, 2019 & 2026 (USD Million)
      Fig.21	Global Academic Research Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
      Fig.22	Global Clinical Research Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
      Fig.23	Global Hospitals & Clinics Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
      Fig.24	Global Pharma & Biotech Entities Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
      Fig.25	Global Other users Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
      Fig.26	Global Next Generation Sequencing (NGS) Market Share, by Region, 2019 & 2026 (USD Million)
      Fig.27	North America Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
      Fig.28	U.S. Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
      Fig.29	Canada Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
      Fig.30	Europe Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
      Fig.31	Germany Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
      Fig.32	France Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
      Fig.33	U.K. Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
      Fig.34	Italy Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
      Fig.35	Spain Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
      Fig.36	Rest of Europe Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
      Fig.37	Asia Pacific Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
      Fig.38	China Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
      Fig.39	Japan Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
      Fig.40	India Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
      Fig.41	South  Korea Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
      Fig.42	South-East Asia Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
      Fig.43	Rest of Asia Pacific Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
      Fig.44	Latin America Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
      Fig.45	Brazil Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
      Fig.46	Mexico Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
      Fig.47	Rest of Latin America Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
      Fig.48	The Middle-East and Africa Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
      Fig.49	GCC Countries Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
      Fig.50	South Africa Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
      Fig.51	Rest of Middle-East Africa Next Generation Sequencing (NGS) Market, 2016 – 2026 (USD Million)
      Fig.52	Competitor Market Share – Revenue
      Fig.53	Genomatix GmbH Revenue and Growth Rate
      Fig.54	Genomatix GmbH Market Share
      Fig.55	PierianDx Revenue and Growth Rate
      Fig.56	PierianDx Market Share
      Fig.57	DNASTAR, Inc. Revenue and Growth Rate
      Fig.58	DNASTAR, Inc. Market Share
      Fig.59	Illumina Revenue and Growth Rate
      Fig.60	Illumina Market Share
      Fig.61	QIAGEN Revenue and Growth Rate
      Fig.62	QIAGEN Market Share
      Fig.63	Thermo Fisher Scientific, Inc. Revenue and Growth Rate
      Fig.64	Thermo Fisher Scientific, Inc. Market Share
      Fig.65	F. Hoffman-La Roche Ltd. Revenue and Growth Rate
      Fig.66	F. Hoffman-La Roche Ltd. Market Share
      Fig.67	Oxford Nanopore Technologies Revenue and Growth Rate
      Fig.68	Oxford Nanopore Technologies Market Share
      Fig.69	Eurofins GATC Biotech GmbH Revenue and Growth Rate
      Fig.70	Eurofins GATC Biotech GmbH Market Share
      Fig.71	Perkin Elmer, Inc. Revenue and Growth Rate
      Fig.72	Perkin Elmer, Inc. Market Share
      Fig.73	BGI Revenue and Growth Rate
      Fig.74	BGI Market Share
      Fig.75	Bio-Rad Laboratories, Inc. Revenue and Growth Rate
      Fig.76	Bio-Rad Laboratories, Inc. Market Share
      Fig.77	Market Dynamics
      Fig.78	Global Next Generation Sequencing (NGS) – Value Chain Analysis
      Fig.79	Key Mandates and Regulations
      Fig.80	PESTEL Analysis
      Fig.81	SWOT Analysis
      Fig.82	Technology Roadmap and Timeline
      Fig.83	Market Attractiveness Analysis – By Application
      Fig.84	Market Attractiveness Analysis – By Technology
      Fig.85	Market Attractiveness Analysis – By End-Use
      Fig.86	Market Attractiveness Analysis – By Region
      

      List of Tables

      Table 1	Global Next Generation Sequencing (NGS) Market, 2019 & 2026 (USD Million)
      Table 2	Global Next Generation Sequencing (NGS) Market, by Application, 2016 – 2026 (USD Million)
      Table 3	Global Next Generation Sequencing (NGS) Market, by Technology, 2016 – 2026 (USD Million)
      Table 4	Global Next Generation Sequencing (NGS) Market, by End-Use, 2016 – 2026 (USD Million)
      Table 5	Global Next Generation Sequencing (NGS) Market, by Region, 2016 – 2026 (USD Million)
      Table 6	North America Next Generation Sequencing (NGS) Market, by Country, 2016 – 2026 (USD Million)
      Table 7	North America Next Generation Sequencing (NGS) Market, by Application, 2016 – 2026 (USD Million)
      Table 8	North America Next Generation Sequencing (NGS) Market, by Technology, 2016 – 2026 (USD Million)
      Table 9	North America Next Generation Sequencing (NGS) Market, by End-Use, 2016 – 2026 (USD Million)
      Table 10 Europe Next Generation Sequencing (NGS) Market, by Country, 2016 – 2026 (USD Million)
      Table 11 Europe Next Generation Sequencing (NGS) Market, by Application, 2016 – 2026 (USD Million)
      Table 12 Europe Next Generation Sequencing (NGS) Market, by Technology, 2016 – 2026 (USD Million)
      Table 13 Europe Next Generation Sequencing (NGS) Market, by End-Use, 2016 – 2026 (USD Million)
      Table 14 Asia Pacific Next Generation Sequencing (NGS) Market, by Country, 2016 – 2026 (USD Million)
      Table 15 Asia Pacific Next Generation Sequencing (NGS) Market, by Application, 2016 – 2026 (USD Million)
      Table 16 Asia Pacific Next Generation Sequencing (NGS) Market, by Technology, 2016 – 2026 (USD Million)
      Table 17 Asia Pacific Next Generation Sequencing (NGS) Market, by End-Use, 2016 – 2026 (USD Million)
      Table 18 Latin America Next Generation Sequencing (NGS) Market, by Country, 2016 – 2026 (USD Million)
      Table 19 Latin America Next Generation Sequencing (NGS) Market, by Application, 2016 – 2026 (USD Million)
      Table 20 Latin America Next Generation Sequencing (NGS) Market, by Technology, 2016 – 2026 (USD Million)
      Table 21 Latin America Next Generation Sequencing (NGS) Market, by End-Use, 2016 – 2026 (USD Million)
      Table 22 The Middle-East and Africa Next Generation Sequencing (NGS) Market, by Country, 2016 – 2026 (USD Million)
      Table 23 The Middle-East and Africa Next Generation Sequencing (NGS) Market, by Application, 2016 – 2026 (USD Million)
      Table 24 The Middle-East and Africa Next Generation Sequencing (NGS) Market, by Technology, 2016 – 2026 (USD Million)
      Table 25 The Middle-East and Africa Next Generation Sequencing (NGS) Market, by End-Use, 2016 – 2026 (USD Million)
      Table 26 Global Next Generation Sequencing (NGS) Market - Company Revenue Analysis, 2016 – 2019 (USD Million)
      Table 27 Global Next Generation Sequencing (NGS) Market - Company Revenue Share Analysis, 2016 – 2019 (%)
      Table 28 Acquisitions and Mergers
      Table 29 Market Drivers – Impact Analysis
      Table 30 Market Restraints
      Table 31 Market Opportunities
      

Industry Major Market Players

  • Genomatix GmbH
  • PierianDxDNASTAR Inc.
  • Eurofins GATC Biotech GmbH
  • Illumina
  • QIAGEN
  • Thermo Fisher Scientific Inc.
  • F. Hoffman-La Roche Ltd.
  • Oxford Nanopore Technologies
  • Perkin Elmer Inc.
  • Bio-Rad Laboratories Inc.
  • BGI

Safe and Secure SSL Encrypted

Choose License Type

Inquiry For Buying

COVID-19 Pandemic Impacts

Our Analysts and Consultants are working ceaselessly to congregate, identify, analyze, and portray the Actual Impacts of COVID-19 Global Pandemic in each of our published as well as ongoing research reports to Redefine and Revise Current and Future Market Trends, Growth Rates, And Market Size Projections across the Globe as well as in different Regions and individual Countries.

have a question

HAVE A QUESTION? Executive will help you find what you are looking for.


REQUEST CUSTOMIZATION

Still haven't found what you're looking for? Speak to our Custom Research Team

Learn More
Facts & Factors provides an array of marketing and business research solutions distinctly designed by our expertise for the clients.
Copyright © 2021 Facts & Factors. All Rights Reserved. Sitemap - Privacy Policy - Terms & Conditions